Precision NanoSystems (PNI), a leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction.
Precision NanoSystems (PNI) has been acquired by Danaher Corporation's Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics.
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and ...
Clinical Solutions offers clients a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of Gene and Cell Therapies...